Sg Americas Securities, LLC Oric Pharmaceuticals, Inc. Transaction History

Sg Americas Securities, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	BUY	$4.95 - $8.4 $114,592 - $194,460	23,150 New	23,150 $180,000
Q1 2022 Apr 29, 2022	SELL	$4.54 - $16.1 $61,971 - $219,765	-13,650 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$12.01 - $20.3 $139,135 - $235,175	-11,585 Reduced 45.91%	13,650 $201,000
Q3 2021 Nov 01, 2021	BUY	$15.9 - $25.22 $401,236 - $636,426	25,235 New	25,235 $528,000
Q2 2021 Aug 12, 2021	SELL	$17.37 - $25.34 $98,922 - $144,311	-5,695 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$23.67 - $36.85 $134,800 - $209,860	5,695 New	5,695 $140,000
Q4 2020 Feb 04, 2021	SELL	$20.32 - $39.8 $1.87 Million - $3.66 Million	-91,997 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$19.5 - $31.26 $1.36 Million - $2.17 Million	69,520 Added 309.29%	91,997 $2.3 Million
Q2 2020 Jul 20, 2020	BUY	$25.68 - $38.12 $577,209 - $856,823	22,477 New	22,477 $758,000

112

63.1M

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $406M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.